Andrew S Boyer insider trades

Open-market stock purchases and sales by Andrew S Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 24, 2010.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +116%.

Recent trades

DateStockTradeValue
Sep 1, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)—
Aug 21, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)—
Mar 4, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$255K
Mar 4, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$265K
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$331K
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$162K
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$2.7M
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AMRX Amneal Pharmaceuticals, Inc: 2 buys, 6 sales, last Sep 1, 2026
  • WPI Watson Pharmaceuticals Inc: other filings, last Mar 14, 2010

Get free alerts when Andrew S Boyer files a new trade →